Chromosomal aneuploidy is responsible for a significant proportion of pregnancy failures, whether conceived naturally or through in vitro fertilization (IVF). In an effort to improve the success rate of IVF, screening embryos for aneuploidy - or pre-implantation genetic screening (PGS) - has been proposed as a means of ensuring only euploid embryos are selected for transfer. Early PGS approaches were based on fluorescence in situ hybridization testing, and have been shown not to improve live birth rates. Recent developments in genetic testing technologies - such as next-generation sequencing and quantitative polymerase chain reaction, coupled with embryo biopsy at the blastocyst stage - have shown promise in improving IVF outcomes, but they remain to be validated in adequately powered, prospective randomized trials. The extent to which IVF with PGS lowers the a priori risk of aneuploidy in ongoing pregnancies so conceived has been poorly described, rendering it difficult to incorporate the potential benefit of PGS into existing prenatal aneuploidy screening regimens such as cell-free DNA testing or conventional combined nuchal translucency and maternal biochemistry assessment. Further data on the sensitivity and specificity of various forms of molecular PGS testing would improve our understanding of the effectiveness and accuracy of these technologies. This, in addition to further research into methods of risk combination and assessment, would allow us to help our patients make better- informed decisions about whether or not to proceed with invasive diagnostic tests.

Keywords:
Pre-implantation genetic testing, Pre-implantation genetic screening, Pre-implantation genetic diagnosis, Prenatal diagnosis, Aneuploidy
1.
Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE, Armstrong EG, Nisula BC: Incidence of early loss of pregnancy. N Engl J Med 1988;319:189-194.
2.
Wells D, Levy B: Cytogenetics in reproductive medicine: the contribution of comparative genomic hybridization (CGH). Bioessays 2003;25:289-300.
3.
Harper JC, Coonen E, Handyside AH, Winston RML, Hopman AHN, Delhanty JDA: Mosaicism of autosomes and sex chromosomes in morphologically normal, monospermic preimplantation human embryos. Prenat Diagn 1995;15:41-49.
4.
Delhanty JD, Wells D, Harper JC: Genetic diagnosis before implantation. BMJ 1997;315:828-829.
5.
Munné S, Magli C, Bahçe M, Fung J, Legator M, Morrison L, Cohert J, Gianaroli L: Preimplantation diagnosis of the aneuploidies most commonly found in spontaneous abortions and live births: XY, 13, 14, 15, 16, 18, 21, 22. Prenat Diagn 1998;18:1459-1466.
6.
Gardner RM, Sutherland GR, Shaffer LG: Chromosome Abnormalities and Genetic Counseling. Cambridge, Cambridge University Press, 2004.
7.
Hassold T, Hunt P: To err (meiotically) is human: the genesis of human aneuploidy. Nat Rev Genet 2001;2:280-291.
8.
National Perinatal Statistics Unit (Australia): Australia's mothers and babies 2013: perinatal statistics series No 31. Canberra, AIHW National Perinatal Statistics Unit, 2013.
9.
Meldrum DR: Introduction: preimplantation genetic screening is alive and very well. Fertil Steril 2013;100:593-594.
10.
Kuliev A, Verlinsky Y: The role of preimplantation genetic diagnosis in women of advanced reproductive age. Curr Opin Obstet Gynecol 2003;15:233-238.
11.
Hanson C, Hardarson T, Lundin K, Bergh C, Hillensjö T, Stevic J, Westin C, Selleskog U, Rogberg L, Wikland M: Re-analysis of 166 embryos not transferred after PGS with advanced reproductive maternal age as indication. Hum Reprod 2009;24:2960-2964.
12.
Milán M, Cobo AC, Rodrigo L, Mateu E, Mercader A, Buendía P, Peinado V, Delgado A, Mir P, Simón C, Remohí J, Pellicer A, Rubio C: Redefining advanced maternal age as an indication for preimplantation genetic screening. Reprod Biomed Online 2010;21:649-657.
13.
Munné S, Alikani M, Tomkin G, Grifo J, Cohen J: Embryo morphology, developmental rates, and maternal age are correlated with chromosome abnormalities. Fertil Steril 1995;64:382-391.
14.
Orris JJ, Taylor TH, Gilchrist JW, Hallowell SV, Glassner MJ, Wininger JD: The utility of embryo banking in order to increase the number of embryos available for preimplantation genetic screening in advanced maternal age patients. J Assist Reprod Genet 2010;27:729-733.
15.
Platteau P, Staessen C, Michiels A, Van Steirteghem A, Liebaers I, Devroey P: Preimplantation genetic diagnosis for aneuploidy screening in women older than 37 years. Fertil Steril 2005;84:319-324.
16.
Rubio C, Bellver J, Rodrigo L, Bosch E, Mercader A, Vidal C, De los Santos MJ, Giles J, Labarta E, Domingo J, Crespo J, Remohí J, Pellicer A, Simón C: Preimplantation genetic screening using fluorescence in situ hybridization in patients with repetitive implantation failure and advanced maternal age: two randomized trials. Fertil Steril 2013;99:1400-1407.
17.
Schoolcraft WB, Katz-Jaffe MG, Stevens J, Rawlins M, Munné S: Preimplantation aneuploidy testing for infertile patients of advanced maternal age: a randomized prospective trial. Fertil Steril 2009;92:157-162.
18.
Blockeel C, Schutyser V, De Vos A, Verpoest W, De Vos M, Staessen C, Haentjens P, Van der Elst J, Devroey P: Prospectively randomized controlled trial of PGS in IVF/ICSI patients with poor implantation. Reprod Biomed Online 2008;17:848-854.
19.
Greco E, Bono S, Ruberti A, Lobascio AM, Greco P, Biricik A, Spizzichino L, Greco A, Tesarik J, Minasi MG, Fiorentino F: Comparative genomic hybridization selection of blastocysts for repeated implantation failure treatment: a pilot study. Biomed Res Int 2014;2014:457913.
20.
Munné S, Chen S, Fischer J, Colls P, Zheng X, Stevens J, Escudero T, Oter M, Schoolcraft B, Simpson JL, Cohen J: Preimplantation genetic diagnosis reduces pregnancy loss in women aged 35 years and older with a history of recurrent miscarriages. Fertil Steril 2005;84:331-335.
21.
Shahine LK, Lathi RB: Embryo selection with preimplantation chromosomal screening in patients with recurrent pregnancy loss. Semin Reprod Med 2014;32:93-99.
22.
Harper JC, Wilton L, Traeger-Synodinos J, Goossens V, Moutou C, SenGupta SB, Pehlivan Budak T, Renwick P, De Rycke M, Geraedts JP, Harton G: The ESHRE PGD consortium: 10 years of data collection. Hum Reprod Update 2012;18:234-247.
23.
Gleicher N, Kushnir VA, Barad DH: Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol 2014;12:22.
24.
Cimadomo D, Capalbo A, Ubaldi FM, Scarica C, Palagiano A, Canipari R, Rienzi L: The impact of biopsy on human embryo developmental potential during preimplantation genetic diagnosis. Biomed Res Int 2016;2016:7193075.
25.
Li M, DeUgarte CM, Surrey M, Danzer H, DeCherney A, Hill DL: Fluorescence in situ hybridization reanalysis of day-6 human blastocysts diagnosed with aneuploidy on day 3. Fertil Steril 2005;84:1395-1400.
26.
Barbash-Hazan S, Frumkin T, Malcov M, Yaron Y, Cohen T, Azem F, Amit A, Ben- Yosef D: Preimplantation aneuploid embryos undergo self-correction in correlation with their developmental potential. Fertil Steril 2009;92:890-896.
27.
Munné S, Velilla E, Colls P, Garcia Bermudez M, Vemuri MC, Steuerwald N, Garrisi J, Cohen J: Self-correction of chromosomally abnormal embryos in culture and implications for stem cell production. Fertil Steril 2005;84:1328-1334.
28.
Pan M, Li FT, Li Y, Jiang FM, Li DZ, Lau TK, Liao C: Discordant results between fetal karyotyping and non-invasive prenatal testing by maternal plasma sequencing in a case of uniparental disomy 21 due to trisomic rescue. Prenat Diagn 2013;33:598-601.
29.
Greco E, Minasi MG, Fiorentino F: Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med 2015;373:2089-2090.
30.
Eggermann T, Soellner L, Buiting K, Kotzot D: Mosaicism and uniparental disomy in prenatal diagnosis. Trends Mol Med 2015;21: 77-87.
31.
Taylor TH, Gitlin SA, Patrick JL, Crain JL, Wilson JM, Griffin DK: The origin, mechanisms, incidence and clinical consequences of chromosomal mosaicism in humans. Hum Reprod Update 2014;20:571-581.
32.
Scott KL, Hong KH, Scott RT Jr: Selecting the optimal time to perform biopsy for preimplantation genetic testing. Fertil Steril 2013;100:608-614.
33.
Munné S: Preimplantation genetic diagnosis for aneuploidy and translocations using array comparative genomic hybridization. Curr Genomics 2012;13:463-470.
34.
Harper JC, Coonen E, Ramaekers FC, Delhanty JD, Handyside AH, Winston RM, Hopman AH: Identification of the sex of human preimplantation embryos in two hours using an improved spreading method and fluorescent in-situ hybridization (FISH) using directly labelled probes. Hum Reprod 1994;9:721-724.
35.
Griffin DK, Wilton LJ, Handyside AH, Winston RM, Delhanty JD: Dual fluorescent in situ hybridisation for simultaneous detection of X and Y chromosome-specific probes for the sexing of human preimplantation embryonic nuclei. Hum Genet 1992;89:18-22.
36.
Coonen E, Dumoulin JC, Dreesen JC, Bras M, Evers JL, Geraedts JP: Clinical application of FISH for sex determination of embryos in preimplantation diagnosis of X-linked diseases. J Assist Reprod Genet 1996;13:133-136.
37.
Scriven PN, Bossuyt PMM: Diagnostic accuracy: theoretical models for preimplantation genetic testing of a single nucleus using the fluorescence in situ hybridization technique. Hum Reprod 2010;25:2622-2628.
38.
Munné S: Analysis of chromosome segregation during preimplantation genetic diagnosis in both male and female translocation heterozygotes. Cytogenet Genome Res 2005;111:305-309.
39.
Debrock S, Melotte C, Spiessens C, Peeraer K, Vanneste E, Meeuwis L, Meuleman C, Frijns JP, Vermeesch JR, D'Hooghe TM: Preimplantation genetic screening for aneuploidy of embryos after in vitro fertilization in women aged at least 35 years: a prospective randomized trial. Fertil Steril 2010;93:364-373.
40.
Hardarson T, Hanson C, Lundin K, Hillensjö T, Nilsson L, Stevic J, Reismer E, Borg K, Wikland M, Bergh C: Preimplantation genetic screening in women of advanced maternal age caused a decrease in clinical pregnancy rate: a randomized controlled trial. Hum Reprod 2008;23:2806-2812.
41.
Mastenbroek S, Twisk M, van Echten-Arends J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, Vogel NEA, Arts EGJ, de Vries JWA, Bossuyt PM, Buys CHC, Heineman MJ, Repping S, van der Veen F: In vitro fertilization with preimplantation genetic screening. N Engl J Med 2007;357:9.
42.
Staessen C, Platteau P, Van Assche E, Michiels A, Tournaye H, Camus M, Devroey P, Liebaers I, Van Steirteghem A: Comparison of blastocyst transfer with or without preimplantation genetic diagnosis for aneuploidy screening in couples with advanced maternal age: a prospective randomized controlled trial. Hum Reprod 2004;19:2849-2858.
43.
Stevens J, Wale P, Surrey ES, Schoolcraft WB, Gardner DK: Is aneuploidy screening for patients aged 35 or over beneficial? A prospective randomized trial. Fertil Steril 2004;82: S249.
44.
Jansen RPS, Bowman MC, de Boer KA, Leigh DA, Lieberman DB, McArthur SJ: What next for preimplantation genetic screening (PGS)? Experience with blastocyst biopsy and testing for aneuploidy. Hum Reprod 2008;23:1476-1478.
45.
Mersereau JE, Pergament E, Zhang X, Milad MP: Preimplantation genetic screening to improve in vitro fertilization pregnancy rates: a prospective randomized controlled trial. Fertil Steril 2008;90:1287-1289.
46.
Meyer LR, Klipstein S, Hazlett WD, Nasta T, Mangan P, Karande VC: In vitro fertilization: a prospective randomized controlled trial of preimplantation genetic screening in the ‘good prognosis' patient. Fertil Steril 2009;91:1731-1738.
47.
Staessen C, Verpoest W, Donoso P, Haentjens P, Van der Elst J, Liebaers I, Devroey P: Preimplantation genetic screening does not improve delivery rate in women under the age of 36 following single-embryo transfer. Hum Reprod 2008;23:2818-2825.
48.
Wilton L, Voullaire L, Sargeant P, Williamson R, McBain J: Preimplantation aneuploidy screening using comparative genomic hybridization or fluorescence in situ hybridization of embryos from patients with recurrent implantation failure. Fertil Steril 2003;80:860-868.
49.
Kuliev A, Verlinsky Y: Meiotic and mitotic nondisjunction: lessons from preimplantation genetic diagnosis. Hum Reprod Update 2004;10:401-407.
50.
Fritz MA: Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now? Hum Reprod 2008;23:2617-2621.
51.
Coulam CB, Jeyendran RS, Fiddler M, Pergament E: Discordance among blastomeres renders preimplantation genetic diagnosis for aneuploidy ineffective. J Assist Reprod Genet 2007;24:37-41.
52.
Brezina PR, Kutteh WH: Clinical applications of preimplantation genetic testing. BMJ 2015;350:g7611.
53.
Wells D, Alfarawati S, Fragouli E: Use of comprehensive chromosomal screening for embryo assessment: microarrays and CGH. Mol Hum Reprod 2008;14:703-710.
54.
Munné S, Grifo J, Wells D: Mosaicism: ‘survival of the fittest' versus ‘no embryo left behind'. Fertil Steril 2016;105:1146-1149.
55.
Lissens W, Sermon K: Preimplantation genetic diagnosis: current status and new developments. Hum Reprod 1997;12:1756-1761.
56.
Alfarawati S, Fragouli E, Colls P, Wells D: First births after preimplantation genetic diagnosis of structural chromosome abnormalities using comparative genomic hybridization and microarray analysis. Hum Reprod 2011;26:1560-1574.
57.
Geraedts J, Montag M, Magli MC, Repping S, Handyside A, Staessen C, Harper J, Schmutzler A, Collins J, Goossens V, van der Ven H, Vesela K, Gianaroli L: Polar body array CGH for prediction of the status of the corresponding oocyte. Part I: clinical results. Hum Reprod 2011;26:3173-3180.
58.
Fishel S, Gordon A, Lynch C, Dowell K, Ndukwe G, Kelada E, Thornton S, Jenner L, Cater E, Brown A, Garcia-Bernardo J: Live birth after polar body array comparative genomic hybridization prediction of embryo ploidy - the future of IVF? Fertil Steril 2010;93:1006.e7-e10.
59.
Gutiérrez-Mateo C, Colls P, Sánchez-García J, Escudero T, Prates R, Ketterson K, Wells D, Munné S: Validation of microarray comparative genomic hybridization for comprehensive chromosome analysis of embryos. Fertil Steril 2011;95:953-958.
60.
Fiorentino F, Caiazzo F, Napolitano S, Spizzichino L, Bono S, Sessa M, Nuccitelli A, Biricik A, Gordon A, Rizzo G, Baldi M: Introducing array comparative genomic hybridization into routine prenatal diagnosis practice: a prospective study on over 1,000 consecutive clinical cases. Prenat Diagn 2011;31:1270-1282.
61.
Colls P, Escudero T, Fischer J, Cekleniak NA, Ben-Ozer S, Meyer B, Damien M, Grifo JA, Hershlag A, Munné S: Validation of array comparative genome hybridization for diagnosis of translocations in preimplantation human embryos. Reprod Biomed Online 2012;24:621-629.
62.
Yang Z, Liu J, Collins GS, Salem SA, Liu X, Lyle SS, Peck AC, Sills ES, Salem RD: Selection of single blastocysts for fresh transfer via standard morphology assessment alone and with array CGH for good prognosis IVF patients: results from a randomized pilot study. Mol Cytogenet 2012;5:24.
63.
Yang Z, Salem SA, Liu X, Kuang Y, Salem RD, Liu J: Selection of euploid blastocysts for cryopreservation with array comparative genomic hybridization (aCGH) results in increased implantation rates in subsequent frozen and thawed embryo transfer cycles. Mol Cytogenet 2013;6:32.
64.
Treff NR, Levy B, Su J, Northrop LE, Tao X, Scott RT Jr: SNP microarray-based 24 chromosome aneuploidy screening is significantly more consistent than FISH. Mol Hum Reprod 2010;16:583-589.
65.
Treff NR, Su J, Tao X, Levy B, Scott RT Jr: Accurate single cell 24 chromosome aneuploidy screening using whole genome amplification and single nucleotide polymorphism microarrays. Fertil Steril 2010;94:2017-2021.
66.
Scott RT Jr, Ferry K, Su J, Tao X, Scott K, Treff NR: Comprehensive chromosome screening is highly predictive of the reproductive potential of human embryos: a prospective, blinded, nonselection study. Fertil Steril 2012;97:870-875.
67.
Treff NR, Tao X, Ferry KM, Su J, Taylor D, Scott RT Jr: Development and validation of an accurate quantitative real-time polymerase chain reaction-based assay for human blastocyst comprehensive chromosomal aneuploidy screening. Fertil Steril 2012;97:819-824.
68.
Forman EJ, Hong KH, Ferry KM, Tao X, Taylor D, Levy B, Treff NR, Scott RT Jr: In vitro fertilization with single euploid blastocyst transfer: a randomized controlled trial. Fertil Steril 2013;100:100-107.e1.
69.
Scott RT Jr, Upham KM, Forman EJ, Hong KH, Scott KL, Taylor D, Tao X, Treff NR: Blastocyst biopsy with comprehensive chromosome screening and fresh embryo transfer significantly increases in vitro fertilization implantation and delivery rates: a randomized controlled trial. Fertil Steril 2013;100:697-703.
70.
Bianchi DW, Wilkins-Haug L: Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem 2014;60: 78-87.
71.
Yin X, Tan K, Vajta G, Jiang H, Tan Y, Zhang C, Chen F, Chen S, Zhang C, Pan X, Gong C, Li X, Lin C, Gao Y, Liang Y, Yi X, Mu F, Zhao L, Peng H, Xiong B, Zhang S, Cheng D, Lu G, Zhang X, Lin G, Wang W: Massively parallel sequencing for chromosomal abnormality testing in trophectoderm cells of human blastocysts. Biol Reprod 2013;88:69.
72.
Fiorentino F, Biricik A, Bono S, Spizzichino L, Cotroneo E, Cottone G, Kokocinski F, Michel CE: Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos. Fertil Steril 2014;101:1375-1382.
73.
Fiorentino F, Bono S, Biricik A, Nuccitelli A, Cotroneo E, Cottone G, Kokocinski F, Michel C-E, Minasi MG, Greco E: Application of next-generation sequencing technology for comprehensive aneuploidy screening of blastocysts in clinical preimplantation genetic screening cycles. Hum Reprod 2014;29:2802-2813.
74.
Yang Z, Lin J, Zhang J, Fong WI, Li P, Zhao R, Liu X, Podevin W, Kuang Y, Liu J: Randomized comparison of next-generation sequencing and array comparative genomic hybridization for preimplantation genetic screening: a pilot study. BMC Med Genomics 2015;8:30.
75.
Scott RT Jr, Upham KM, Forman EJ, Zhao T, Treff NR: Cleavage-stage biopsy significantly impairs human embryonic implantation potential while blastocyst biopsy does not: a randomized and paired clinical trial. Fertil Steril 2013;100:624-630.
76.
Chen M, Wei S, Hu J, Quan S: Can comprehensive chromosome screening technology improve IVF/ICSI outcomes? A meta-analysis. PLoS One 2015;10:e0140779.
77.
Wong KM, Repping S, Mastenbroek S: Limitations of embryo selection methods. Semin Reprod Med 2014;32:127-133.
78.
Lee E, Illingworth P, Wilton L, Chambers GM: The clinical effectiveness of preimplantation genetic diagnosis for aneuploidy in all 24 chromosomes (PGD-A): systematic review. Hum Reprod 2015;30:473-483.
79.
Malone FD, Canick JA, Ball RH, Nyberg DA, Comstock CH, Bukowski R, Berkowitz RL, Gross SJ, Dugoff L, Craigo SD, Timor-Tritsch IE, Carr SR, Wolfe HM, Dukes K, Bianchi DW, Rudnicka AR, Hackshaw AK, Lambert-Messerlian G, Wald NJ, D'Alton ME: First-trimester or second-trimester screening, or both, for Down's syndrome. N Engl J Med 2005;353:2001-2011.
80.
Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M, van den Boom D, Bombard AT, Deciu C, Grody WW, Nelson SF, Canick JA: DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13:913-920.
81.
Norton ME, Jacobsson B, Swamy GK, Laurent LC, Ranzini AC, Brar H, Tomlinson MW, Pereira L, Spitz JL, Hollemon D, Cuckle H, Musci TJ, Wapner RJ: Cell-free DNA analysis for noninvasive examination of trisomy. N Engl J Med 2015;372:1589-1597.
82.
Norton ME, Jelliffe-Pawlowski LL, Currier RJ: Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing. Obstet Gynecol 2014;124:979-986.
83.
Fasouliotis SJ, Schenker JG: Preimplantation genetic diagnosis principles and ethics. Hum Reprod 1998;13:2238-2245.
84.
De Vos A, Van Steirteghem A: Aspects of biopsy procedures prior to preimplantation genetic diagnosis. Prenat Diagn 2001;21:767-780.
85.
Verlinsky Y, Rechitsky S, Evsikov S, White M, Cieslak J, Lifchez A, Valle J, Moise J, Strom CM: Preconception and preimplantation diagnosis for cystic fibrosis. Prenat Diagn 1992;12:103-110.
86.
Treff NR, Su J, Tao X, Frattarelli JL, Miller KA, Scott RT Jr: Characterization of the source of human embryonic aneuploidy using microarray-based 24 chromosome preimplantation genetic diagnosis (mPGD) and aneuploid chromosome fingerprinting. Fertil Steril 2008;90:S37.
87.
Coonen E: Pre-implantation diagnosis of genetic disease. Eur J Obstet Gynecol Reprod Biol 1996;67:81-83.
88.
Harper JC, Delhanty JD: Preimplantation genetic diagnosis. Curr Opin Obstet Gynecol 2000;12:67-72.
89.
Dumoulin JC, Bras M, Coonen E, Dreesen J, Geraedts JP, Evers JL: Effect of Ca2+/Mg2+-free medium on the biopsy procedure for preimplantation genetic diagnosis and further development of human embryos. Hum Reprod 1998;13:2880-2883.
90.
Cohen J, Wells D, Munné S: Removal of 2 cells from cleavage stage embryos is likely to reduce the efficacy of chromosomal tests that are used to enhance implantation rates. Fertil Steril 2007;87:496-503.
91.
Schoolcraft WB, Katz-Jaffe MG: Comprehensive chromosome screening of trophectoderm with vitrification facilitates elective single-embryo transfer for infertile women with advanced maternal age. Fertil Steril 2013;100:615-619.
92.
Delhanty JD, Griffin DK, Handyside AH, Harper J, Atkinson GH, Pieters MH, Winston RM: Detection of aneuploidy and chromosomal mosaicism in human embryos during preimplantation sex determination by fluorescent in situ hybridisation (FISH). Hum Mol Genet 1993;2:1183-1185.
93.
Delhanty JD, Harper JC, Ao A, Handyside AH, Winston RM: Multicolour FISH detects frequent chromosomal mosaicism and chaotic division in normal preimplantation embryos from fertile patients. Hum Genet 1997;99:755-760.
94.
Munné S, Weier HU, Grifo J, Cohen J: Chromosome mosaicism in human embryos. Biol Reprod 1994;51:373-379.
95.
Northrop LE, Treff NR, Levy B, Scott RT Jr: SNP microarray-based 24 chromosome aneuploidy screening demonstrates that cleavage-stage FISH poorly predicts aneuploidy in embryos that develop to morphologically normal blastocysts. Mol Hum Reprod 2010;16:590-600.
96.
Harton GL, Munné S, Surrey M, Grifo J, Kaplan B, McCulloh DH, Griffin DK, Wells D: Diminished effect of maternal age on implantation after preimplantation genetic diagnosis with array comparative genomic hybridization. Fertil Steril 2013;100:1695-1703.
97.
Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT Jr: Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and single-nucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fertil Steril 2011;96:638-640.
98.
Shapiro BS, Daneshmand ST, Restrepo H, Garner FC, Aguirre M, Hudson C: Matched-cohort comparison of single-embryo transfers in fresh and frozen-thawed embryo transfer cycles. Fertil Steril 2013;99:389-392.
99.
Voullaire L, Wilton L: Comparative genomic hybridization on single cells. Methods Mol Med 2007;132:101-115.
100.
Wells D, Delhanty JD: Comprehensive chromosomal analysis of human preimplantation embryos using whole genome amplification and single cell comparative genomic hybridization. Mol Hum Reprod 2000;6:1055-1062.
101.
Wells D, Escudero T, Levy B, Hirschhorn K, Delhanty JD, Munné S: First clinical application of comparative genomic hybridization and polar body testing for preimplantation genetic diagnosis of aneuploidy. Fertil Steril 2002;78:543-549.
102.
Wilton L, Williamson R, McBain J, Edgar D, Voullaire L: Birth of a healthy infant after preimplantation confirmation of euploidy by comparative genomic hybridization. N Engl J Med 2001;345:1537-1541.
103.
Clewley JP: DNA microarrays. Commun Dis Public Health 2000;3:71-72.
104.
Keltz MD, Vega M, Sirota I, Lederman M, Moshier EL, Gonzales E, Stein D: Preimplantation genetic screening (PGS) with comparative genomic hybridization (CGH) following day 3 single cell blastomere biopsy markedly improves IVF outcomes while lowering multiple pregnancies and miscarriages. J Assist Reprod Genet 2013;30:1333-1339.
105.
Rabinowitz M, Ryan A, Gemelos G, Hill M, Baner J, Cinnioglu C, Banjevic M, Potter D, Petrov DA, Demko Z: Origins and rates of aneuploidy in human blastomeres. Fertil Steril 2012;97:395-401.
106.
Treff NR, Northrop LE, Kasabwala K, Su J, Levy B, Scott RT Jr: Single nucleotide polymorphism microarray-based concurrent screening of 24-chromosome aneuploidy and unbalanced translocations in preimplantation human embryos. Fertil Steril 2011;95:1606-1612.e1-2.
107.
Johnson DS, Hill M, Abae M, Frederick J, Swanson M, Rabinowitz M: First clinical application of DNA microarrays for translocations and inversions. Fertil Steril 2010;93: S13-S14.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.